Abiopharma

Clinical trial NCT03832361: collaborators added: AbbVie.

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split

Clinical trial NCT06846281: start date: 2025-07-23 → 2025-06-23.

Clinical trial NCT06501092 updates: 1. completion date: 2026-07-31 → 2027-07-31 2. primary completion date: 2026-07-31 → 2027-07-31

Clinical trial NCT06045988 updates: 1. start date: 2026-02-01 → 2026-07-01 2. completion date: 2026-08-01 → 2026-12-01 3. primary completion date: 2026-08-01 → 2026-12-01

Clinical trial NCT06631677: status: TEMPORARILY_NOT_AVAILABLE → AVAILABLE.

Clinical trial NCT06107738 updates: 1. completion date: 2026-12-31 → 2028-12-31 2. primary completion date: 2025-12-31 → 2027-12-31

Clinical trial NCT07158905 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-08-03 → 2026-06-23

Clinical trial NCT07262567 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-12-01 → 2025-12-04

Clinical trial NCT07471841 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-07-01